Walmart to alter opioid prescription policies at its pharmacies
Date: 2018-05-08   Author: Ojaswita Kutepatil  Category: #news

In a bid to curb opioid misuse and abuse, Walmart Inc., has announced that it will only fill first-time opioid prescriptions for acute pain to seven days or even less across the United States. Reportedly, the initiative will be commenced within 60 days and comes on the heels of the rising number of healthcare entities tightening the rules surrounding the filing of opioid prescriptions.

Sources reveal that pharmacies, beginning 1st January 2020, will be restricting the dosage of opioids to not more than 50 MMEs (morphine milligrams equivalent) per day and will require online prescriptions for controlled substances. The e-prescriptions are deemed to minimize error and prevent prescription frauds.  

Marybeth Hays, Walmart’s executive VP of health and wellness and consumables, was quoted stating that the company is taking action in the fight against the nation’s opioid epidemic. In an effort to continue to be a part of the solution, Walmart is introducing new programs, tools and policies that will be aimed at addressing the critical issues faced by the patients & communities.

Reliable reports claim that the initiatives will also be applicable to Sam’s Club Pharmacies, which is owned by Walmart. Several other companies have also been making similar efforts to help mitigate the opioid epidemic.

As per industry analysts, these proposals have disclosed that limitations are important to lower the number of painkillers that are available to be unlawfully diverted, stem overprescribing, and lower the potential for addiction.

Opioid overdose crisis and the proposal for its limits have garnered significant support from several shareholders, owing to which a bill in the Senate will be restricting the initial prescriptions for acute pain to 3 days.

Meanwhile, the AMA (American Medical Association) has countered that the limits over opioid dosage & supply are arbitrary and believes that the decision needs to be left between the physician and the patient.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Associate Content writer, where she pens down write-ups pertaining to the ...

Read More

More from Ojaswita


Post Recommendents

Brisbane City Council votes to ban single-use bottles & plastic straws
Author: Dhananjay Punekar

The Brisbane City Council, one of Australia’s largest metropolitan jurisdictions, has apparently announced to become the most environment friendly council after it pledged to ban single-use plastic bottles, heliu...


Santos’s Board support for Harbour’s bid treading on uncertain waters
Author: Dhananjay Punekar

Harbour Energy, a U.S. based energy investment firm, is still doubtful over its plans to acquire Santos, a leading oil & gas producer, for nearly USD 13.7 billion. Sources cite that after nearly a month of diligenc...


Total requests for sanction waiver to continue with South Pars project
Author: Dhananjay Punekar

Total S.A., a France-based Oil & Gas firm, has threatened to withdraw from the proposed natural gas venture in Iran if the U.S. President persists with his decision of not waiving off the secondary sanctions on int...